Skip to main content

Correction to: Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism

The Original Article was published on 07 April 2024

Correction to: Cell Biosci (2024) 14: 46

https://doi.org/10.1186/s13578-024-01226-4

In the publication of this article [1], the authors have identified two errors in the initial version. Now they have been included in this correction.

Firstly, for the calculation of the Urine Albumin-to-Creatinine Ratio (UACR), the authors mistakenly used incorrect parameters when calculating due to the variable mislabeling in data processing. Eventually, the wrong calculation of UACR led to its incorrect values in the baseline characteristics of NHANES participants (Table 1) and the corresponding results in the generalized linear model (Additional file 1: Tables S2, S3) and mediation analysis (Additional file 1: Tables S4, S5). As a result of this error, the following changes have been made to the originally published version of this article:

The fourth and fifth sentences of the eleventh paragraph of the Results originally read “Overall, there were statistically significant differences between non-CKD and CKD participants in terms of sex, age, race, educational attainment, BMI, smoking status, CVD, DM, hypertension, Klotho, TC, TG, WBC, Neu, Mono, SII, NLR, MLR, SIRI, PIV, eGFR, serum creatinine, uric acid and serum urea nitrogen (all P < 0.05). However, no significant differences were observed between the two groups for other variables, including HDL, LDL, Lym, PLR and UACR (all P > 0.05).” In the corrected version, UACR has a statistically significant difference between non-CKD and CKD participants. The sentences are corrected as “Overall, there were statistically significant differences between non-CKD and CKD participants in terms of sex, age, race, educational attainment, BMI, smoking status, CVD, DM, hypertension, Klotho, TC, TG, WBC, Neu, Mono, SII, NLR, MLR, SIRI, PIV, eGFR, serum creatinine, UACR, uric acid and serum urea nitrogen (all P < 0.05). However, no significant differences were observed between the two groups for other variables, including HDL, LDL, Lym and PLR (all P > 0.05).”

The second and third sentences of the twelfth paragraph of the Results originally read “Using the lowest tertile of Klotho level (T1) as the reference, the β and 95% CI for TC, eGFR, serum urea nitrogen, serum creatinine, and uric acid in the moderate tertile of Klotho level (T2) were β -3.227 (95% CI -6.288, -0.167), β 1.689 (95% CI 0.596, 2.782), β -0.409 (95% CI -0.668, -0.150), β -0.033 (95% CI -0.050, -0.016) and β -0.172 (95% CI -0.255, -0.088) in the adjusted model (all P < 0.05). Furthermore, using the T1 as the reference, the β and 95% CI for WBC, Neu, PLR, PIV, SII, TC, TG, eGFR, serum urea nitrogen, serum creatinine and uric acid in the highest tertile of Klotho level (T3) were β -0.174 (95% CI -0.319, -0.028), β -0.160 (95% CI -0.288, -0.032), β -5.865 (95% CI -9.028, -2.702), β -27.806 (95% CI -43.335, -12.277), β -43.053 (95% CI -65.437, -20.669), β -4.335 (95% CI -7.629, -1.041), β -12.756 (95% CI -23.960, -1.552), β 2.799 (95% CI 1.792, 3.806), β -0.589 (95% CI -0.892, -0.285), β -0.050 (95% CI -0.068, -0.032) and β -0.351 (95% CI -0.434, -0.269) in the adjusted model (all P < 0.05).” The sentences are corrected as “Using the lowest tertile of Klotho level (T1) as the reference, the β and 95% CI for TC, eGFR, serum urea nitrogen, serum creatinine, uric acid and UACR in the moderate tertile of Klotho level (T2) were β -3.227 (95% CI -6.288, -0.167), β 1.689 (95% CI 0.596, 2.782), β -0.409 (95% CI -0.668, -0.150), β -0.033 (95% CI -0.050, -0.016), β -0.172 (95% CI -0.255, -0.088) and β -13.721 (95% CI -25.918, -1.525) in the adjusted model (all P < 0.05). Furthermore, using the T1 as the reference, the β and 95% CI for WBC, Neu, PLR, PIV, SII, TC, TG, eGFR, serum urea nitrogen, serum creatinine, uric acid and UACR in the highest tertile of Klotho level (T3) were β -0.174 (95% CI -0.319, -0.028), β -0.160 (95% CI -0.288, -0.032), β -5.865 (95% CI -9.028, -2.702), β -27.806 (95% CI -43.335, -12.277), β -43.053 (95% CI -65.437, -20.669), β -4.335 (95% CI -7.629, -1.041), β -12.756 (95% CI -23.960, -1.552), β 2.799 (95% CI 1.792, 3.806), β -0.589 (95% CI -0.892, -0.285), β -0.050 (95% CI -0.068, -0.032), β -0.351 (95% CI -0.434, -0.269) and β -14.360 (95% CI -26.809, -1.912) in the adjusted model (all P < 0.05).”

Replace the incorrect UACR calculation results in Table 1 and Additional file 1: Tables S2, S3, S4, S5. The correct Additional file 1: Tables S2, S3, S4, S5 are available on the Cell & Bioscience’s website from the date of publication of this note.

Secondly, for the presentation of continuous variables of the baseline characteristics of NHANES participants (Table 1), the authors mistakenly labeled “SE” (standard error) as “SD” (standard deviation).

As a result of this error, the following changes have been made to the originally published version of this article:

The eighth sentence of the nineteenth paragraph of the Methods originally read “Continuous variables were described as mean ± standard deviation (SD), while categorical variables were presented as n (%).” In the corrected version, the sentence is corrected as “Continuous variables were described as mean ± standard error (SE), while categorical variables were presented as n (%).” The same correction is made to the Table 1 legend (“Continuous variables were presented as Mean ± SD” is replaced by “Continuous variables were presented as Mean (SE)”).

The correct Table 1 is given in this correction.

Table 1 Descriptive characteristics of NHANES participants

References

  1. Liu J, Wang H, Liu Q, Long S, Wu Y, Wang N, et al. Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism. Cell Biosci. 2024;14(1):46. https://doi.org/10.1186/s13578-024-01226-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Gang Chen, Miao Lin or Junping Wen.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The online version of the original article can be found at https://doi.org/10.1186/s13578-024-01226-4.

Electronic supplementary material

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Wang, H., Liu, Q. et al. Correction to: Klotho exerts protection in chronic kidney disease associated with regulating inflammatory response and lipid metabolism. Cell Biosci 14, 97 (2024). https://doi.org/10.1186/s13578-024-01263-z

Download citation

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13578-024-01263-z